{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:12:19Z","timestamp":1793383939762,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00259-020-05132-y","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:06:56Z","timestamp":1606435616000},"page":"1915-1931","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":154,"title":["Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET\/CT in patients with various cancers"],"prefix":"10.1007","volume":"48","author":[{"given":"Sanjana","family":"Ballal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav Prasad","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euy Sung","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasko S.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Roesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samta","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhavi","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreedharan Thankarajan","family":"ArunRaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulochana","family":"Sarswat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4378-5584","authenticated-orcid":false,"given":"Chandrasekhar","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"key":"5132_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1927;8:519\u201330.","journal-title":"J Gen Physiol"},{"key":"5132_CR2","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1158\/1078-0432.CCR-07-0074","volume":"13","author":"DA Mankoff","year":"2007","unstructured":"Mankoff DA, Eary JF, Link JM, Muzi M, Rajendran JG, Spence AM, et al. Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond. Clin Cancer Res. 2007;13:3460\u20139.","journal-title":"Clin Cancer Res"},{"key":"5132_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3348\/kjr.2006.7.1.57","volume":"7","author":"JM Chang","year":"2006","unstructured":"Chang JM, Lee HJ, Goo JM, Lee HY, Lee JJ, Chung JK, et al. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J Radiol. 2006;7:57\u201369.","journal-title":"Korean J Radiol"},{"key":"5132_CR4","first-page":"104","volume":"4","author":"B Davidson","year":"2014","unstructured":"Davidson B, Trope CG, Reich R. The role of the tumor stroma in ovarian cancer. Front Oncol. 2014;4:104.","journal-title":"Front Oncol"},{"key":"5132_CR5","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","volume":"87","author":"P Garin-Chesa","year":"1990","unstructured":"Garin-Chesa P, Old LJ, Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci. 1990;87:7235\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"5132_CR6","first-page":"4767","volume":"62","author":"DJ Cheng","year":"2002","unstructured":"Cheng DJ, Dunbrack RL, Valianou M, Rogatko A, Alpaugh RK, Weine LM. Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res. 2002;62:4767\u201372.","journal-title":"Cancer Res"},{"key":"5132_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4161\/cbt.13.3.18696","volume":"13","author":"R Liu","year":"2012","unstructured":"Liu R, Li H, Liu L, Yu J, Ren X. Fibroblast activation protein: a potential therapeutic target in cancer. Cancer Biol Ther. 2012;13:123\u20139.","journal-title":"Cancer Biol Ther"},{"key":"5132_CR8","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1021\/jm500031w","volume":"57","author":"K Jansen","year":"2014","unstructured":"Jansen K, Heirbaut L, Verkerk R, Cheng JD, Joossens J, Cos P, et al. Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP). J Med Chem. 2014;57:3053\u201374.","journal-title":"J Med Chem"},{"key":"5132_CR9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.118.215913","volume":"60","author":"FL Giesel","year":"2019","unstructured":"Giesel FL, Kratochwil C, Lindner T, Marschalek MM, Loktev A, Lehnert W, et al. 68Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers. J Nucl Med. 2019;60:386\u201392.","journal-title":"J Nucl Med"},{"key":"5132_CR10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. 68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med. 2019;60:801\u20135.","journal-title":"J Nucl Med"},{"key":"5132_CR11","doi-asserted-by":"crossref","unstructured":"Meyer C, Dahlbom M, Lindner T, Vauclin S, Mona C, Slavik R, et al. Radiation dosimetry and biodistribution of 68Ga-FAPI-46 PET imaging in cancer patients. J Nucl Med. 2020;61:1171-7.","DOI":"10.2967\/jnumed.119.236786"},{"key":"5132_CR12","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2967\/jnumed.118.224469","volume":"60","author":"A Loktev","year":"2019","unstructured":"Loktev A, Lindner T, Burger EM, Altmann A, Giesel F, Kratochwil C, et al. Development of fibroblast activation protein-targeted radiotracers with improved tumor retention. J Nucl Med. 2019;60:1421\u20139.","journal-title":"J Nucl Med"},{"key":"5132_CR13","doi-asserted-by":"publisher","unstructured":"Moon ES, Elvas F, Vliegen G, Lombaerde SD, Vangestel C, Bruycker SD, et al. Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA 5m chelators. EJNMMI Radiopharm Chem. 2020;5:19. https:\/\/doi.org\/10.1186\/s41181-020-00102-z.","DOI":"10.1186\/s41181-020-00102-z"},{"key":"5132_CR14","doi-asserted-by":"publisher","unstructured":"Ballal S, Yadav MP, Kramer V, Moon ES, Roesch F, Tripathi M, et al. A theranostic approach of [68Ga]Ga-DOTA.SA.FAPi PET\/CT-guided [177Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy. Eur J Nucl Med Mol Imaging. 2020. https:\/\/doi.org\/10.1007\/s00259-020-04990-w.","DOI":"10.1007\/s00259-020-04990-w"},{"key":"5132_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0146-6453(03)00002-2","volume":"32","author":"J Valentin","year":"2002","unstructured":"Valentin J. Basic anatomical and physiological data for use in radiological protection: reference values. A report of age- and gender-related differences in the anatomical and physiological characteristics of reference individuals. ICRP Publication 89. Ann ICRP. 2002;32:1\u2013277.","journal-title":"Ann ICRP"},{"key":"5132_CR16","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/cncr.24797","volume":"116","author":"L Ferrer","year":"2010","unstructured":"Ferrer L, Kraeber-Bodere F, Bodet-Milin C, Rousseau C, Gouill SL, Wegener WA, et al. Three methods assessing redmarrow dosimetry in lymphoma patients treated with radioimmunotherapy. Cancer. 2010;116:1093\u2013100.","journal-title":"Cancer."},{"issue":"Suppl 1","key":"5132_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122\u201350.","journal-title":"J Nucl Med"},{"issue":"1","key":"5132_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/JTO.0b013e318200f983","volume":"6","author":"JN Mandrekar","year":"2011","unstructured":"Mandrekar JN. Measures of interrater agreement. J Thorac Oncol. 2011;6(1):6\u20137.","journal-title":"J Thorac Oncol"},{"key":"5132_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00418-014-1292-0","volume":"143","author":"P Busek","year":"2015","unstructured":"Busek P, Hrabal P, Fric P, Sedo A. Co-expression of the homologous proteases fibroblast activation protein and dipeptidyl peptidase-IV in the adult human Langerhans islets. Histochem Cell Biol. 2015;143:497\u2013504.","journal-title":"Histochem Cell Biol"},{"key":"5132_CR20","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J, Zhao L, Hao B, Wu J, et al. Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020;47:1820\u201332.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5132_CR21","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00432-013-1471-8","volume":"139","author":"Y Liao","year":"2013","unstructured":"Liao Y, Ni Y, He R, Liu W, Du J. Clinical implications of fibroblast activation protein-\u03b1 in non-small cell lung cancer after curative resection: a new predictor for prognosis. J Cancer Res Clin Oncol. 2013;139:1523\u20138.","journal-title":"J Cancer Res Clin Oncol"},{"key":"5132_CR22","doi-asserted-by":"publisher","first-page":"e1155","DOI":"10.1038\/cddis.2014.122","volume":"5","author":"H Wang","year":"2014","unstructured":"Wang H, Wu Q, Liu Z, Luo X, Fan Y, Liu Y, et al. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN\/PI3K\/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death Dis. 2014;5:e1155.","journal-title":"Cell Death Dis"},{"key":"5132_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.canlet.2011.01.011","volume":"303","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Tang H, Cai J, Zhang T, Guo J, Feng D, et al. Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion. Cancer Lett. 2011;303:47\u201355.","journal-title":"Cancer Lett"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-05132-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-020-05132-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-05132-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T09:07:07Z","timestamp":1620724027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-020-05132-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5132"],"URL":"https:\/\/doi.org\/10.1007\/s00259-020-05132-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,26]]},"assertion":[{"value":"22 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ref. No IECPG-22\/2020.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical clearance"}},{"value":"we obtained written informed consent from all the patients before commencing the investigational PET\/CT Scan.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The current work has not been submitted for review or is not under acceptance for publication in any journal.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}